Stocks Comparison
Marpai vs Progyny: revenue, profit, margins and growth compared
Marpai brought in $18.1M of revenue in fiscal 2025, Progyny $1.3B in fiscal 2025. Revenue changed by -35.8% at Marpai and +10.4% at Progyny on the year before, so Progyny grew faster. Marpai kept -91.5% of its revenue as net profit, Progyny 4.5%.
Side by side, latest fiscal year
| MRAI | PGNY | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $18.1M | $1.3B |
| Revenue growth | -35.8% | +10.4% |
| Net income | -$16.6M | $58.5M |
| Net margin | -91.5% | 4.5% |
| Free cash flow | n/a | $191.8M |
| Free cash flow margin | n/a | 14.9% |
| Earnings per share (diluted) | -$0.95 | $0.65 |
| Cash | $133K | $112.2M |
| Debt | $19.4M | n/a |
| Price to earnings | n/a | 39.3 |
| Market value | $91M | $2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #481 of 742 · Health care | #140 of 742 · Health care |
Over the years
MRAI $18.1MPGNY $1.3B
MRAI -$16.6MPGNY $58.5M
MRAI -91.5%PGNY 4.5%
MRAI -35.8%PGNY +10.4%
MRAI -$35.6MPGNY $191.8M
Questions about Marpai and Progyny
Which is bigger by revenue, Marpai or Progyny?
Progyny is bigger by revenue: $1.3B in fiscal 2025, against $18.1M for Marpai in fiscal 2025.
Which keeps more of its revenue as profit, Marpai or Progyny?
Marpai had a net margin of -91.5% in fiscal 2025; Progyny had 4.5% in fiscal 2025.
Which grew revenue faster, Marpai or Progyny?
In their latest fiscal years revenue changed by -35.8% at Marpai and +10.4% at Progyny.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.